Group I (n=46) | Group II (n=75) |
Significance (group I v group II) | |
PUD (%) | 33 (72) | 35 (47) | χ2=7.281; p<0.01 |
NUD (%) | 13 (28) | 40 (53) | |
Men (%) | 31 (67) | 49 (65) | χ2=0.054; p=0.816 |
Age (SD (range)) | 15.7 (23–85) | 13.6 (23–82) | p=0.830 |
Initial cure rate1-150 (%) | 26/46 (57) | 51/711-152 (72) | χ2=2.908; p=0.08 |
Final cure rate1-151 (%) | 27/46 (59) | 46/71 (65) | χ2=0.442; p=0.506 |
Final cure rate PUD (%) | 22/33 (67)1-153 | 26/34 (76)1-153 | χ2=0.792; p=0.373 |
Final cure rate NUD (%) | 5/13 (39) | 20/37 (54) | χ2=0.936; p=0.330 |
↵1-150 Based on CLO test, culture, and histopathology results of the post-treatment biopsy specimens.
↵1-151 Taking PCR on post-treatment biopsy specimens into account.
↵1-152 Follow up samples from four cases were not available.
↵1-153 Difference between final cure rate of patients with peptic ulcer disease (PUD) compared with patients with non-ulcer dyspepsia (NUD) was not significant in group I (χ2=3.06; p=0.08), but was in group II (χ2=3.903; p=0.04).